Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial
Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational...
Read MoreBellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational...
Read MoreCyroport delivers for Celularity Source Reference Celularity has agreed to use temperature...
Read MoreNeo Stem Therapies Inc Address 420 Lexington Ave #450, New York, NY 10170 Phone (212) 584-4180...
Read MoreRegenerative Cell Institute Address 2911 N Tenaya Way #200, Las Vegas, NV 89128 Phone (702)...
Read More